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Since the introduction of extracorporeal hemodialysis for the management
of renal failure, its usefulness in the treatment of otherwise fatal poisoning
by various chemical agents has been repeatedly demonstrated. Among these
agents have been various barbiturates,' salicylates,' and bromide.' Recent
experience with a case of intoxication with ethynyl-cyclohexyl carbamate
(Fig. 1), a short-acting nonbarbiturate hypnotic,' provided an opportunity
to demonstrate its dialyzability. Although the poisoning proved fatal in this
instance, the ability to remove an appreciable quantity of the drug by
hemodialysis suggests that patients with severe intoxication coming under
observation earlier may be treated by this method more successfully.
CASE HISTORY
M.F.K., NCMH Unit No. 05-26-69
A 24-year-old single white female graduate student was brought to the Emergency
Ward of the North Carolina Memorial Hospital at 9:30 p.m. on 9/25/58. She had been
found comatose in her apartment shortly before with the beginning of a "suicide note"
and an empty prescription bottle discovered near her body. The prescription had been
refilled one week previously after a long interval for at least thirty 0.5 gram tablets of
ethynyl-cyclohexyl-carbamate (ValmidR, Lilly). The patient was last heard from
specifically 26 hours prior to the discovery prompted by her having missed several
specific appointments throughout the day. Past medical history, obtained from friends
and previous medical record, was noncontributory. There was no personal history of
diabetes, epilepsy, trauma, syncope, cardiac, pulmonary or renal disease. Family history
was also noncontributory.
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Physical examination showed a well-developed, well-nourished white female, coma-
tose and cyanotic. There was no evidence of vomiting. Respirations were shallow at
24/minute. The blood pressure and pulse were unobtainable. Temperature was 95.40 F.,
p.r. Hydration was fair. External examination revealed a 6x6 inch pressure point
over the right hip, suggesting that the patient had lain on that side for a long period.
There was no evidence of trauma to the head or the rest of the body, nor was there sign
of fracture. The pupils were normal in size with the left pupil slightly larger than the
right; there was no pupillary response to light. Ear, nose, and throat were normal.
The neck was supple and free of venous distention. There were numerous rhonchi
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thelial cells, the urinary sediment was
in the stool.
heard bilaterally in the chest; these were
cleared considerably on suction. The heart
was normal in size and showed a normal
sinus rhythm at a rate of 78. The aortic and
pulmonary second heart sounds were equal
in intensity and there were no murmurs.
The abdomen was soft with normal bowel
sounds audible. No masses or organs were
palpable. Neurological examination showed
coma, areflexia, generalized flaccidity, com-
plete unresponsiveness to painful stimuli, and
no spontaneous movement. Plantar response
was normal bilaterally.
Laboratory data indicated an hematocrit
of 60 per cent and a white blood cell count
of 7875 cells/cu. mm. The sedimentation rate
and differential cell count were normal.
Urinalysis showed a cloudy, amber urine,
pH. 4.5, specific gravity 1.018, no protein or
acetone, 2+ sugar. Except for many epi-
clear. There was no gross or occult blood
On arrival at the hospital, an endotracheal tube was inserted and oxygen therapy
begun with clearing of the cyanosis but no change in neurological status. An infusion
of l-norepinephrine was also started at once with a rise in blood pressure to 90/60
and a return of palpable, symmetrical peripheral pulses. A search of the literature and
consultation with the manufacturer and with several poison centers throughout the
country revealed no specific therapy or antidote.
Laboratory data shortly after entry revealed a blood CO2 content of 20 mEq./L. and
a blood sugar of 368 mg.%o. The blood sugar rose over the next twelve hours to 832
mg.% and then fell to 444 mg.%o prior to the onset of hemodialysis. The hyperglycemia
was concomitant with massive 1-norepinephrine infusions. The blood and urine remained
free of acetone throughout, and the patient did not appear to be in diabetic coma. The
blood sugar fell to 144 mg.% on hemodialysis. Urine sugar fluctuated between 2+ and
4+ on catheterized specimens. During the initial twelve hours the urine output dwindled
as the patient developed 3+ albuminuria, cylindruria, and microscopic hematuria and
pyuria. Specific gravity remained at 1.018 and pH at 4.5.
Despite continuous support by vasopressor agents, oxygen, endotracheal suction,
bronchoscopy for left lower lobe atalectasis of the lung, antibiotics because of x-ray
evidence of pneumonitis, gastric suction because of coffee-ground vomitus, and the
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administration at various times of dextrose in water, hypertonic and isotonic saline and
plasma, the patient continued to show clinical and chemical evidence of deterioration.
It became necessary to maintain respiration with a Bennett respirator; the need for
vasopressor agents for the maintenance of detectable blood pressure increased and with
it the need to administer excessive volumes of fluid in the face of diminishing urine
output and the suspected development of acute renal failure. The blood urea nitrogen
was normal, but the acidosis worsened over the initial 12 hours of hospitalization; the
CO2 content fell to 9.5 mEq./L.; other chemical values were sodium 115 mEq./L. at
the time the blood sugar was 386 mg.%, potassium 3.0 mEq./L., chloride 93 mEq./L.,
total protein 4.1 gr.%o, phosphorus 7.7 mg.%. Arterial blood pH was 6.88, pC02 43 mm.
Hg and bicarbonate 9.3 mEq./L., representative of a mixed metabolic and respiratory
acidosis. Electrocardiogram showed slight prolongation of the QT interval with a
sinus rhythm at a rate of 79/minute.
In the hope that ethinamate would prove dialyzable and in the face of the continued
moribund state of the patient, hemodialysis was begun 18 hours after entry by means
of a disposable coil artificial kidney (Travenol Laboratories, Inc., Morton Grove,
Illinois). After six hours of hemodialysis, there was no evidence of clinical or chemical
improvement. Hydrocortisone was administered without noticeable salutory effect.
Arterial blood showed a pH of 6.65, CO2 content 8.1 mEq./L., sodium 133 mEq./L.,
and potassium 4.8 mEq./L. The hematocrit had fallen to 45. Because of the demonstra-
tion of an acetylenic compound in an ether extract of the dialysate on qualitative test
with alkaline ammoniacal silver solution (a control test with commercial ethinamate
was also positive), it was decided to centinue the dialysis for another six hours. At the
end of this period the arterial blood C02 content had risen to 10.1 without significant
change in other chemical studies, except for the aforementioned fall in blood sugar to
144 mg.o. At this point, after 12 hours of hemodialysis, the patient developed pulmonary
edema and expired. Post-mortem examination showed pneumonia, multiple pulmonary
emboli with infarction, hepatic and splenic congestion, and bilateral cortical necrosis of
the kidneys.
DISCUSSION
Ethynyl-cyclohexyl carbamate (ethinamate, ValmidR Lilly) is a short-
acting nonbarbiturate hypnotic drug with a short duration of action.8"' 5.9
The therapeutic dose is considered to be very much less than the toxic dose,
but little has been done to elucidate its pharmacology. One patient is
reported to have taken 28 gm. of the medication without fatal outcome.' No
antidote is known. The kidney plays no role in the metabolic transformation
of ethinamate while data on the role of the liver are contradictory."'
The metabolic fate of ethinamate in rats has recently been clarified by
McMahon.' Seventy-three per cent of a 50 mg./Kg. intraperitoneal dose
(labeled with C-14 on the carbonyl group) was eliminated within eight
hours, 10 per cent as respiratory CO2 and 63 per cent in the urine as
unchanged ethinamate and some metabolite of the drug. The metabolite was
identified by paper chromatography and subjection to the action of
B8-glucuronidase as mainly hydroxy-ethinamate and its 83-glucuronide in
194
Volutne 32, December 1959Extracorporeal hemnodialysis DAVIS, BLYTHE, NEWTON, WELT
approximately equal amounts. Of the urinary excretory products, 2 per cent
was unchanged ethinamate, 89 per cent hydroxy-ethinamate and 9 per cent
unidentified metabolites. The acetylenic group remained unchanged by the
body. Whether hydroxy-ethinamate has any hypnotic effect has not been
reported.
There are many unexplained features in the course of the patient reported
above. The rapid onset of a very severe acidosis without ketosis and clini-
cally not resembling diabetic acidosis despite the elevated blood sugar
(possibly attributable to norepinephrine administration) remains unex-
plained. A test of a normal urine specimen to which a small amount of
ethinamate had been added showed only a trace reaction to ClinitestR
tablet and a negative reaction to glucose oxidase impregnated urinary test
paper, suggesting that the ethinamate alone could not account for the
elevated sugar. While the hyponatremia could be explained on the basis of
the elevated blood sugar, the marked elevation of the hematocrit remains
mysterious in the face of the absence of evidence of significant dehydration.
Possible shifts of fluid internally out of the plasma may account for this, but
the stimulus and mechanism for this shift are unrecognized here.
Hemodialysis was undertaken because of the lack of progress of the
patient already moribund and in cardiovascular collapse, in the hope that
the drug would prove dialyzable. The dialysates from the two six-hour runs
on the artificial kidney were very kindly analysed by Dr. John S. Welles
(The Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana)
by a chromatographic technique. The total amount of ethinamate and
hydroxy-ethinamate removed is indicated in Table 1:
TABLE 1.
Ethinamate Hydroxyethinamate
Dialysate No. 1 345 mg. 190 mg.
Dialysate No. 2 460 mg. 240 mg.
Total 805 mg. 430 mg.
Although only 1.23 gm. of ethinamate are accounted for on the two dialyses,
hemodialysis was not begun until an estimated 40-44 hours following the
ingestion of the medication, whose action and stay in the body are known to
be short. The amount removed may, in this light, be significant. For this
reason, then, the demonstration of the dialyzability of ethinamate and its
metabolic product appeared worthy of a report in the hope that cases of
severe intoxication appearing earlier in their course may have a more
favorable outcome. The appearance of a quantity of the drug in the second
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six-hour dialysate equal to the amount in the first dialysate may not be a
reflection of poor dialyzability from the blood but may, rather, indicate an
intracellular location across a membrane of limited permeability to the drug.
The effect of the patient's extreme mixed metabolic and respiratory acidosis
on this permeability is conjectural. In the absence of plasma level determina-
tions, the gradient and effect of protein binding cannot be evaluated. The
need for prolonged or repeated hemodialysis in cases of ethinamate
intoxication should therefore be anticipated.
SUMMARY
A fatal case of ethinamate intoxication is reported. The patient was
treated by hemodialysis unsuccessfully, but the demonstration of significant
amounts of ethinamate and its metabolic product in the dialysate warrants
an early trial of this mode of therapy in other severe cases of ethinamate
intoxication unresponsive to other measures.
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